Evidence map›Paper›PMID 41972702›Full record

ReviewCells2026

Fibroblast-Based Cell Therapy: Molecular Background, Current Therapies and Future Perspectives.

Paulina Bihuniak, Patrycja Stodolak, Piotr Kulig, Bogusław Machaliński

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Paulina BihuniakPharmaceutical Facility of Pomeranian Medical University, Pomeranian Medical University, 70-252 Szczecin, Poland.
Patrycja StodolakPharmaceutical Facility of Pomeranian Medical University, Pomeranian Medical University, 70-252 Szczecin, Poland.ORCID 0009-0009-6044-0474
Piotr KuligPharmaceutical Facility of Pomeranian Medical University, Pomeranian Medical University, 70-252 Szczecin, Poland.ORCID 0000-0002-8695-8863
Bogusław MachalińskiDepartment of Hematology and Transplantology, Pomeranian Medical University, 71-252 Szczecin, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblasts are mesenchymal cells which physiologically possess numerous functions and belong to basic cellular components necessary to maintain tissue homeostasis and are essential for extracellular matrix formation and maintenance. In addition, fibroblasts are of paramount importance in regeneration and wound healing as they interact with the immune system. These unique properties determine their great utility in cell therapies in the field of regenerative medicine. This review summarizes the mechanisms of action and clinical applications of fibroblast-based therapies as well as highlighting the future perspectives including the use of allogeneic cells.

Indexed as

Cell- and Tissue-Based TherapyFibroblastsAnimalsHumansRegenerative MedicineWound Healingaesthetic medicineanti-aging medicineATMPcell therapyfibroblastsregenerative medicinewound healing

Identifiers

PMID41972702
PMCPMC13072187

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.